Cargando…
How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786612/ https://www.ncbi.nlm.nih.gov/pubmed/35012701 http://dx.doi.org/10.1017/S204579602100072X |
_version_ | 1784639149380206592 |
---|---|
author | Taillefer de Laportalière, T. Yrondi, A. Jullien, A. Cestac, P. Montastruc, F. |
author_facet | Taillefer de Laportalière, T. Yrondi, A. Jullien, A. Cestac, P. Montastruc, F. |
author_sort | Taillefer de Laportalière, T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8786612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87866122022-02-08 How to deprescribe esketamine in resistant depression? A point of view after first clinical uses Taillefer de Laportalière, T. Yrondi, A. Jullien, A. Cestac, P. Montastruc, F. Epidemiol Psychiatr Sci Letter to the Editor Cambridge University Press 2022-01-11 /pmc/articles/PMC8786612/ /pubmed/35012701 http://dx.doi.org/10.1017/S204579602100072X Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Letter to the Editor Taillefer de Laportalière, T. Yrondi, A. Jullien, A. Cestac, P. Montastruc, F. How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title | How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title_full | How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title_fullStr | How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title_full_unstemmed | How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title_short | How to deprescribe esketamine in resistant depression? A point of view after first clinical uses |
title_sort | how to deprescribe esketamine in resistant depression? a point of view after first clinical uses |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786612/ https://www.ncbi.nlm.nih.gov/pubmed/35012701 http://dx.doi.org/10.1017/S204579602100072X |
work_keys_str_mv | AT tailleferdelaportalieret howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses AT yrondia howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses AT julliena howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses AT cestacp howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses AT montastrucf howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses |